Intrahepatic Cholangiocarcinoma  >>  cisplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cisplatin / Generic mfg.
CRUK-ABC-02, NCT00262769: Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Completed
3
324
Europe
cisplatin, CDDP, cis-diamminedichloroplatinum(II), cisplatinum, gemcitabine hydrochloride, Gemzar
University College, London, Eli Lilly and Company
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
08/08
 

Download Options